CARL vs KMI · rev $50.5M vs P/E 24, rev $9.30B
Carlsmed, Inc. Common Stock (CARL) versus Kinder Morgan Inc (KMI) — a side-by-side from cached financials, not a winner call.
Carlsmed, Inc. Common Stock (CARL) is a health information services company listed on NASDAQ.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Latest reported CARL revenue for 2025-12-31 was $50.5M. Net income was -$29.6M. Revenue was up 85.9% from 2024-12-31 to 2025-12-31. CARL currently screens at market cap $299.7M.
Latest reported KMI revenue for 2026-06-30 was $9.30B. Net income was $1.84B. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
CARL currently screens at market cap $299.7M. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Not investment advice. Open the CARL and KMI stock pages for the full models.
Not investment advice.